Imfinzi

{
  "id": "MLC-T-ONC-004187",
  "term": "Imfinzi",
  "field": "Oncology and biomedicine",
  "definition": "A drug that binds to the protein PD-L1 to help immune cells kill cancer cells better and is used to treat different types of cancer. Imfinzi is used alone or with other drugs to treat adults with certain types of biliary tract cancer (including bile duct cancer and gallbladder cancer), bladder cancer, endometrial cancer, hepatocellular carcinoma (a type of liver cancer), non-small cell lung cancer, and small cell lung cancer. It is also being studied in the treatment of other types of cancer. Imfinzi may block PD-L1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called durvalumab.",
  "synonyms": [
    "durvalumab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/imfinzi/"
}